Viewing nowOmena Tablet 40mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Hanpung Pharmaceutical Co., Ltd.

MFDS item code 201905654 · Approved 2019.08.12 · Insurance code 658106970
Treatment of reflux and Zollinger-Ellison syndrome; eradication therapy; treatment and prevention of ulcers and gastrointestinal disorders caused by anti-inflammatory analgesics
This medication can be used long term to treat gastroesophageal reflux disease, especially erosive esophagitis, and to prevent recurrence in esophagitis patients. It also helps alleviate symptoms of gastroesophageal reflux disease without esophagitis. Patients with duodenal ulcers or peptic ulcers caused by Helicobacter pylori infection can be treated in combination with antibiotics for the eradication of Helicobacter pylori. It is effective for treating and preventing upper gastrointestinal symptoms and gastric ulcers related to the use of non-steroidal anti-inflammatory drugs. It is also used in the treatment of Zollinger-Ellison syndrome and maintenance therapy after preventing re-bleeding via intravenous injection. Overall, it is used to treat and prevent various symptoms and complications related to gastrointestinal diseases.
1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to NSAID use. 2) Antibiotic combination therapy for Helicobacter pylori eradication Administer this drug 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with NSAID (nonselective or selective COX-2) use - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting more than 4 weeks have not been conducted. 4) Patients requiring continuous NSAID treatment - Treatment of gastric ulcers associated with NSAID use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with NSAID use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted individually, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with a dose of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided into 2 doses. 6) Maintenance therapy after induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks after induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration. 4. Renal impairment Dosage adjustment is not necessary. Use with caution because there is limited experience administering this drug to patients with severe renal impairment. 5. Hepatic impairment Dosage adjustment is not necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this drug should not exceed 20 mg. 6. Older adults Dosage adjustment is not necessary.
Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. Children under 12 years of age There is no experience with administering this drug to children under 12 years of age.
This medication should not be administered to certain patients. For example, patients with a known allergy or hypersensitivity to this drug or its ingredients, or to medications in the benzimidazole class, should not take it. Additionally, patients with allergies to certain antibiotics or drugs used in conjunction with this medication for the eradication of Helicobacter pylori should also avoid it. Breastfeeding women and patients with a history of myocardial infarction should not use this medication. Various adverse reactions can occur during the use of this drug, so caution is needed. Gastrointestinal symptoms such as headache, abdominal pain, diarrhea, nausea, and vomiting may commonly occur. Rarely, serious side effects such as blood disorders, hypersensitivity reactions, hypomagnesemia, mental confusion, skin rashes, and hepatic dysfunction may occur, so it is important to consult a doctor immediately if any unusual symptoms appear. Regular examinations are required for long-term use of this drug, and any symptoms suggestive of malignancy should be evaluated by a specialist. Since it suppresses gastric acid secretion, there may be a slight increase in the risk of bacterial infections in the gastrointestinal tract. Additionally, patients with osteoporosis or at risk for fractures should exercise caution as there may be an increased risk of fractures with long-term use. This drug has many interactions with other medications, so patients taking other drugs must inform their physician or pharmacist, especially when taking antiviral drugs, antibiotics, anticoagulants, etc. During pregnancy, although no specific abnormalities were found in animal studies, it should be administered cautiously to pregnant women. In breastfeeding cases, it is preferable not to use this medication as it has not been confirmed whether it is excreted in breast milk. In case of overdose, there are no specific antidotes, so treatment will be symptomatic, and it should be stored out of the reach of children. Transferring the medication to another container may cause accidents or degrade quality, so caution is advised.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, agitation, mental confusion, depression, aggression, hallucination, headache, dizziness, altered perception, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrosis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial swelling, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid goiter, irritable bowel syndrome, worsened constipation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorder, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, elevated serum gastrin, tongue disorder, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, aggravated arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, polymyalgia rheumatica, anorexia, apathy, increased appetite, confusion, worsened depression, muscle hypertonicity, sensory impairment, erectile dysfunction, insomnia, migraine, worsened migraine, sleep disorder, tremors, visual field defect, dysmenorrhea, menstrual disorder, vaginitis, worsened asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, pruritus ani, erythematous rash, papulopustular rash, otitis media, olfactory disturbance, taste loss, taste distortion, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, fracture, hypocalcemia, hypokalemia, rhabdomyolysis, myalgia, asthenia, lupus erythematosus, systemic lupus erythematosus, rash, arthralgia, cytopenia, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture, at room temperature between 1 degree and 30 degrees Celsius. Proper storage can help maintain the drug's effectiveness for a longer period.
Pink rectangular film-coated tablet
28 tablets/ptp [7 tablets/Alu-Alu X 4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Hanpung Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.